A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.

Clinical trial NCT00316758 · COMPLETED

Trial details

NCT number: NCT00316758
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetes Mellitus Type 2

Start date: 2006-02-01
Primary completion: 2007-10-01
Enrollment: 259

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.